Innovative CAR-T cell therapy receives FDA Breakthrough Therapy designation

Washington University in St. Louis

Mar 27, 2026

A cell-based immunotherapy designed to treat rare and aggressive types of blood cancer has been granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (F…